Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. clarity

Clarity SIGNED

Real-time renal diagnostic to prevent ICU-acquired Acute Kidney Injury (AKI).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Clarity project word cloud

Explore the words cloud of the Clarity project. It provides you a very rough idea of what is the project "Clarity" about.

monitoring    global    prevalent    risk    outcomes    consistent    strategy    interprets    fluid    showed    requiring    clarity    tested    introduces    data    acquired    plan    ing    decade    kidney    practiced    feasibility    function    industrialization    fluctuations    curative    pittsburgh    market    lost    disease    accurate    die    icu    24    care    renal    days    clinical    critical    serious    organisation    hours    rapid    prevention    aki    composition    injury    million    unfortunately    therapy    worldwide    university    automatically    nursing    hadassah    rms    herzog    patented    sign    prevent    transmitting    provides    alerts    trade    variably    limit    basis    additional    urine    reflects    records    electronic    13    trials    gbd    burden    secured    invaluable    people    mortality    57    renalsense    balance    volume    patient    develops    treatment    significantly    efficacy    patients    staff    changing    intervention    sensor    intensive    hospital    flow    medical    morbidity    time    facilitates    feasible    acute   

Project "Clarity" data sheet

The following table provides information about the project.

Coordinator		 RENAL SENSE LTD 

Organization address
address: HAMARPE 3
city: JERUSALEM
postcode: 91450
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Israel [IL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RENAL SENSE LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

Intensive Care Unit (ICU)-acquired Acute Kidney Injury (AKI) is a prevalent and serious problem, associated with significantly increased morbidity and mortality. According to the Global Burden of Disease (GBD), each year around 1.7 million people worldwide are estimated to die from AKI. AKI develops in over 57% of ICU patients, requiring an average of 3.5 additional hospital days and €13,000 of additional hospital costs per patient. The best treatment for AKI is prevention. Although there is no curative therapy for AKI, research over the past decade identified various means to prevent or limit AKI. Unfortunately, these are not widely known and are variably practiced worldwide resulting in lost opportunities to improve the care and outcomes of patients with AKI. RenalSense introduces Clarity RMS™, a critical care monitoring system that continuously measures urine flow, automatically transmitting to the medical staff real-time data and alerts of fluctuations, on a 24/7 basis. Using patented sensor technology, Clarity measures, analyses and interprets the continuously changing composition and flow volume of urine. This information, which reflects changes in renal function, provides an early sign of AKI risk and facilitates rapid intervention. In addition, it is invaluable for monitoring treatment efficacy and managing fluid balance. The system has been tested during clinical trials with Herzog hospital, Hadassah Medical Organisation and University of Pittsburgh. Analysis of 1,000 study hours showed that electronic measurements with Clarity were more consistent, reliable and accurate than nursing records. During the feasibility assessment, RenalSense will establish a go-to-market strategy, as well as a feasible product development plan and industrialization strategy. The plan for the large-scale clinical trials will be defined, and the participants secured.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLARITY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLARITY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

AnchorGuardian (2019)

AnchorGuardian, providing safety during anchoring by monitoring the position and absolute movement of a ships anchor.

Read More